We’re proud of our efforts to spark a broader, national dialogue on healthcare spending issues. The focus is on digging deeper to understand what is driving…
In Conversation
There is definitely a strong willingness from the Moroccan authorities to harmonize regulatory, pricing and reimbursement processes, switching from sequential to parallel processes
As we prepare for the next steps of the AstraZeneca journey, there is an increased focus beyond the pipeline on innovative approaches in areas like patient-centricity…
In the last 15 years, Morocco has made tremendous progress in the prevention, diagnosis and treatment of cancer thanks to the visionary initiatives of His Majesty…
ViiV Healthcare has a unique positioning both in Belgium and worldwide as the only company 100 percent dedicated to HIV, with a strong commitment to leave…
It is time for [Morocco] to upgrade and create a new type of jobs in the clinical research area, which is aligned to the Ministry of…
In the field of healthcare and life sciences, there is a strong bond between the two countries in terms of investment
In following the British standard of care, we adhere to the same clinical key performance indicators just as if we were sitting in London
It is important for Belgium to implement a strong and long term partnership with the pharmaceutical industry in a context where the supply for life saving…
The UAE and the rest of the GCC countries are setting the standard of fast track registration for other international markets
From the time of Harbour BioMed’s inception in 2016, we have always set out to be a patient-centric global biotech company with multiple forms of value…
My goal is to shape the organization to deliver on clinical trials and engage with partners to bring in this innovation and potentially commercialize our assets…
